Algo version: 0.98b
Excelsior Biopharma Inc is listed at the TWO Exchange
Excelsior Biopharma Inc [6496.TWO]
TWO Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is Excelsior Biopharma Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Excelsior Biopharma Inc pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 13th of July 2021 were paid TWD1 per share. Over the last 7 times between 2015 and 2021, Excelsior Biopharma Inc has paid TWD18 with an average of TWD2.57 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Excelsior Biopharma Inc 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD35.15, you would have made a loss of TWD-5.60 per share or -15.93%

No, the average daily trading liquidity for Excelsior Biopharma Inc is TWD15 983 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Excelsior Biopharma Inc has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Excelsior Biopharma Inc to be medium [0.6 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.